3-Amino-3-azabicyclo[3,3,0]octane

We are 3-Amino-3-azabicyclo[3,3,0]octane CAS:54528-00-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 54528-00-6
Product Name: 3-Amino-3-azabicyclo[3,3,0]octane
Other Name:
3-Amino-3-azabicyclo[3,3,0]octane
Hexahydrocyclopenta[c]pyrrol-2(1H)-amine
3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-amine
N-amino-3-azabicyclo[3.3.0]octane
 
Density: 1.0±0.1 g/cm3
Boiling Point: 188.0±9.0 °C at 760 mmHg
Molecular Formula: C7H14N2
Molecular Weight: 126.200
Flash Point: 73.2±6.7 °C
Exact Mass: 126.115700
PSA: 29.26000
LogP: 0.14
Vapour Pressure: 0.6±0.4 mmHg at 25°C
Index of Refraction: 1.528
 
Specification
Appearance: Yellow to light brown powder
Assay: 98.0~101.0%
Loss on drying: ≤0.20%
Sulphated ash: ≤0.50%
3-Nitroso-3-azabicyclo[3.3.0]octane: ≤20ppm
 
Application
Intermediates of Gliclazide CAS: 21187-98-4.
Be used as  pharmaceutical intermediate, mainly used in the synthesis of the Hypoglycemic drugs Gliclazide.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

3-Amino-3-azabicyclo[3,3,0]octane


Related News: INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.2-Amino-2-methyl-1-propanol In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.1-(2-Fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamidine hydrochloride CAS:256499-19-1 In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.4-Bromophenylboronic acid In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.

Related Products
Product Name
4-Chlorophenylboronic acid Cas:1679-18-1 View Details
2,3-dimercapto-1-propanol Cas:59-52-9 View Details
Optical Brightening Agent CBS-P View Details
1-chloro-7-iodoheptane manufacturer 5,6-diethyl-2,3-dihydro-1H-inden-2-amine,hydrochloride manufacturer Hafnium(Ⅳ) acetylacetonate Cas:17475-67-1 manufacturer 4-Aminobenzonitrile manufacturer 4-Methyl-1-tetralone Cas:19832-98-5 manufacturer